Literature DB >> 28287603

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

Diederik E van der Feen1, Michel Weij2, Annemieke Smit-van Oosten2, Lysanne M Jorna3, Quint A J Hagdorn3, Beatrijs Bartelds3, Rolf M F Berger3.   

Abstract

In this protocol, PAH is induced by combining a 60 mg/kg monocrotalin (MCT) injection with increased pulmonary blood flow through an aorto-caval shunt (MCT+Flow). The shunt is created by inserting an 18-G needle from the abdominal aorta into the adjacent caval vein. Increased pulmonary flow has been demonstrated as an essential trigger for a severe form of PAH with distinct phases of disease progression, characterized by early medial hypertrophy followed by neointimal lesions and the progressive occlusion of the small pulmonary vessels. To measure the right heart and pulmonary hemodynamics in this model, right heart catheterization is performed by inserting a rigid cannula containing a flexible ball-tip catheter via the right jugular vein into the right ventricle. The catheter is then advanced into the main and the more distal pulmonary arteries. The histopathology of the pulmonary vasculature is assessed qualitatively, by scoring the pre- and intra-acinar vessels on the degree of muscularization and the presence of a neointima, and quantitatively, by measuring the wall thickness, the wall-lumen ratios, and the occlusion score.

Entities:  

Mesh:

Year:  2017        PMID: 28287603      PMCID: PMC5408705          DOI: 10.3791/55065

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

1.  Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells.

Authors:  Seiichiro Sakao; Laimute Taraseviciene-Stewart; Jong Deog Lee; Kathy Wood; Carlyne D Cool; Norbert F Voelkel
Journal:  FASEB J       Date:  2005-05-16       Impact factor: 5.191

2.  Distinct loading conditions reveal various patterns of right ventricular adaptation.

Authors:  Marinus A J Borgdorff; Beatrijs Bartelds; Michael G Dickinson; Paul Steendijk; Maartje de Vroomen; Rolf M F Berger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Authors:  Nils P Nickel; Edda Spiekerkoetter; Mingxia Gu; Caiyun G Li; Hai Li; Mark Kaschwich; Isabel Diebold; Jan K Hennigs; Ki-Yoon Kim; Kazuya Miyagawa; Lingli Wang; Aiqin Cao; Silin Sa; Xinguo Jiang; Raymond W Stockstill; Mark R Nicolls; Roham T Zamanian; Richard D Bland; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

5.  Chronic overcirculation-induced pulmonary arterial hypertension in aorto-caval shunt.

Authors:  Alessio Rungatscher; Daniele Linardi; Elisabetta Milani; Grazia Ucci; Elena Nicolato; Flavia Merigo; Beatrice Salvetti; Alessandro Mazzucco; Giovanni Battista Luciani; Giuseppe Faggian
Journal:  Microvasc Res       Date:  2014-05-23       Impact factor: 3.514

6.  Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

Authors:  Mirjam E van Albada; Beatrijs Bartelds; Hans Wijnberg; Saffloer Mohaupt; Michael G Dickinson; Regien G Schoemaker; Krista Kooi; Frans Gerbens; Rolf M F Berger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

Review 7.  Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification.

Authors:  Mirjam E van Albada; Rolf M F Berger
Journal:  Cardiol Young       Date:  2008-01-21       Impact factor: 1.093

8.  Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.

Authors:  Jolyane Meloche; François Potus; Mylène Vaillancourt; Alice Bourgeois; Ian Johnson; Laure Deschamps; Sophie Chabot; Grégoire Ruffenach; Sarah Henry; Sandra Breuils-Bonnet; Ève Tremblay; Valérie Nadeau; Caroline Lambert; Renée Paradis; Steeve Provencher; Sébastien Bonnet
Journal:  Circ Res       Date:  2015-07-29       Impact factor: 17.367

9.  Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.

Authors:  C M Happé; M A de Raaf; N Rol; I Schalij; A Vonk-Noordegraaf; N Westerhof; N F Voelkel; F S de Man; H J Bogaard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-01       Impact factor: 5.464

10.  Serial noninvasive assessment of progressive pulmonary hypertension in a rat model.

Authors:  John E Jones; Lisa Mendes; M Audrey Rudd; Giulia Russo; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  5 in total

1.  Cellular senescence impairs the reversibility of pulmonary arterial hypertension.

Authors:  Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

2.  Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation.

Authors:  Emmanouil Mavrogiannis; Quint A J Hagdorn; Venetia Bazioti; Johannes M Douwes; Diederik E Van Der Feen; Silke U Oberdorf-Maass; Marit Westerterp; Rolf M F Berger
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

3.  Volume Load-Induced Right Ventricular Failure in Rats Is Not Associated With Myocardial Fibrosis.

Authors:  Quint A J Hagdorn; Kondababu Kurakula; Anne-Marie C Koop; Guido P L Bossers; Emmanouil Mavrogiannis; Tom van Leusden; Diederik E van der Feen; Rudolf A de Boer; Marie-José T H Goumans; Rolf M F Berger
Journal:  Front Physiol       Date:  2021-02-26       Impact factor: 4.566

4.  Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling.

Authors:  Marie José Goumans; Rolf M F Berger; Kondababu Kurakula; Quint A J Hagdorn; Diederik E van der Feen; Anton Vonk Noordegraaf; Peter Ten Dijke; Rudolf A de Boer; Harm Jan Bogaard
Journal:  Angiogenesis       Date:  2021-08-11       Impact factor: 9.596

5.  A novel method for measuring pulmonary artery pressure by high-frequency ultrasound-guided transthoracic puncture in rats.

Authors:  Xiaofeng Zhang; Jingtao Li; Decai Zeng; Chunting Liang; Yanfen Zhong; Tongtong Huang; Yingying Mo; Huaqing Rao; Xiaoxiong Pan; Ji Wu
Journal:  Front Cardiovasc Med       Date:  2022-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.